Personal information

United States

Activities

Works (28)

MASLD in people with HIV exhibits higher fibrosis stage despite lower disease activity than in matched controls

Alimentary Pharmacology & Therapeutics
2024-11 | Journal article
Contributors: Daniela S. Allende; Oscar Cummings; Alice L. Sternberg; Cynthia A. Behling; Danielle Carpenter; Ryan M. Gill; Cynthia D. Guy; Matthew M. Yeh; Samer Gawrieh; Richard K. Sterling et al.
Source: check_circle
Crossref

Risk of mortality among patients with alcohol-associated hepatitis in the US from 2007 to 2021

Alcohol
2024-11 | Journal article
Contributors: Wanzhu Tu; Suthat Liangpunsakul; Chi Mai Nguyen; Ryan Healey; Yang Li; Svetlana Radaeva; Samer Gawrieh; Ramon Bataller; Jing Su
Source: check_circle
Crossref

Increases and decreases in liver stiffness measurement are independently associated with the risk of liver-related events in NAFLD

Journal of Hepatology
2024-10 | Journal article
Contributors: Samer Gawrieh; Eduardo Vilar-Gomez; Laura A. Wilson; Francis Pike; David E. Kleiner; Brent A. Neuschwander-Tetri; Anna Mae Diehl; Srinivasan Dasarathy; Kris V. Kowdley; Bilal Hameed et al.
Source: check_circle
Crossref

PNPLA3 rs738409, environmental factors and liver-related mortality in the US population

Journal of Hepatology
2024-10 | Journal article
Contributors: Eduardo Vilar-Gomez; Samer Gawrieh; Raj Vuppalanchi; Carla Kettler; Francis Pike; Niharika Samala; Naga Chalasani
Source: check_circle
Crossref

Diagnostic Ability of Simple Noninvasive Blood Tests to Predict Increased Liver Stiffness in People Living With HIV and Steatotic Liver Disease

American Journal of Gastroenterology
2024-08 | Journal article
Contributors: Richard K. Sterling; Eduardo Vilar-Gomez; Laura A. Wilson; Rohit Loomba; Samer Gawrieh; Jennifer Price; Susanna Naggie; Jordan E. Lake; Sonya Heath; James Tonascia et al.
Source: check_circle
Crossref

Randomized trial of anakinra plus zinc vs. prednisone for severe alcohol-associated hepatitis

Journal of Hepatology
2024-05 | Journal article
Contributors: Samer Gawrieh; Srinivasan Dasarathy; Wanzhu Tu; Patrick S. Kamath; Naga P. Chalasani; Craig J. McClain; Ramon Bataller; Gyongyi Szabo; Qing Tang; Svetlana Radaeva et al.
Source: check_circle
Crossref

Editorial: Updated epidemiology of steatotic liver disease in people with HIV in the United States—Authors' reply

Alimentary Pharmacology & Therapeutics
2024-03 | Journal article
Contributors: Samer Gawrieh; Mark Sulkowski; Naga Chalasani; Rohit Loomba
Source: check_circle
Crossref

Prevalence of steatotic liver disease, MASLD, MetALD and significant fibrosis in people with HIV in the United States

Alimentary Pharmacology & Therapeutics
2024-03 | Journal article
Contributors: Samer Gawrieh; Eduardo Vilar‐Gomez; Tinsay A. Woreta; Jordan E. Lake; Laura A. Wilson; Jennifer C. Price; Susanna Naggie; Richard K. Sterling; Sonya Heath; Kathleen E. Corey et al.
Source: check_circle
Crossref

Thirty-Day Readmissions Are Largely Not Preventable in Patients With Cirrhosis

American Journal of Gastroenterology
2024-02 | Journal article
Contributors: Eric S. Orman; Archita P. Desai; Marwan S. Ghabril; Lauren D. Nephew; Kavish R. Patidar; John Holden; Niharika R. Samala; Samer Gawrieh; Raj Vuppalanchi; Margaret Sozio et al.
Source: check_circle
Crossref

Clinical characteristics and prognosis of hospitalized patients with moderate alcohol‐associated hepatitis

Liver International
2024-01 | Journal article
Contributors: Maria Gaurnizo‐Ortiz; Lauren D. Nephew; Eduardo Vilar‐Gomez; Carla D. Kettler; James E. Slaven; Marwan S. Ghabril; Archita P. Desai; Eric S. Orman; Naga Chalasani; Samer Gawrieh et al.
Source: check_circle
Crossref

Burden of fatty liver and hepatic fibrosis in persons with HIV: A diverse cross-sectional US multicenter study

Hepatology
2023-08 | Journal article
Contributors: Samer Gawrieh; Jordan E. Lake; Paula Debroy; Julia A. Sjoquist; Montreca Robison; Mark Tann; Fatih Akisik; Surya S. Bhamidipalli; Chandan K. Saha; Kimon Zachary et al.
Source: check_circle
Crossref

CAP and LSM as determined by VCTE are independent predictors of all-cause mortality in the US adult population

Hepatology
2023-04 | Journal article
Contributors: Eduardo Vilar-Gomez; Raj Vuppalanchi; Samer Gawrieh; Niharika Samala; Naga Chalasani
Source: check_circle
Crossref

Design of a multicenter randomized clinical trial for treatment of Alcohol-Associated Hepatitis

Contemporary Clinical Trials Communications
2023-04 | Journal article
Contributors: Wanzhu Tu; Samer Gawrieh; Srinivasan Dasarathy; Mack C. Mitchell; Douglas A. Simonetto; Kavish R. Patidar; Craig J. McClain; Ramon Bataller; Gyongyi Szabo; Qing Tang et al.
Source: check_circle
Crossref

Non-alcoholic fatty liver disease is not associated with impairment in health-related quality of life in virally suppressed persons with human immune deficiency virus

PLOS ONE
2023-02-10 | Journal article
Contributors: Samer Gawrieh; Pavel Strnad; Kathleen E. Corey; Jordan E. Lake; Niharika Samala; Archita P. Desai; Paula Debroy; Julia A. Sjoquist; Montreca Robison; Mark Tann et al.
Source: check_circle
Crossref

Comparative Analysis of Global Hepatic Gene Expression in Adolescents and Adults with Non-alcoholic Fatty Liver Disease

2022-12-12 | Preprint
Contributors: Samer Gawrieh; Rebekah Karns; David E. Kleiner; Michael Olivier; Todd Jenkins; Thomas H. Inge; Naga P. Chalasani; Stavra Xanthakos
Source: check_circle
Crossref

High‐quality diet, physical activity, and college education are associated with low risk of NAFLD among the US population

Hepatology
2022-06 | Journal article
Contributors: Eduardo Vilar‐Gomez; Lauren D. Nephew; Raj Vuppalanchi; Samer Gawrieh; Andrea Mladenovic; Francis Pike; Niharika Samala; Naga Chalasani
Source: check_circle
Crossref

Validation of the accuracy of the FAST™ score for detecting patients with at-risk nonalcoholic steatohepatitis (NASH) in a North American cohort and comparison to other non-invasive algorithms

PLOS ONE
2022-04-15 | Journal article
Contributors: Tinsay A. Woreta; Pavel Strnad; Mark L. Van Natta; Mariana Lazo; Arunkumar Krishnan; Brent A. Neuschwander-Tetri; Rohit Loomba; Anna Mae Diehl; Manal F. Abdelmalek; Naga Chalasani et al.
Source: check_circle
Crossref

Saroglitazar, a PPAR‐α/γ Agonist, for Treatment of NAFLD: A Randomized Controlled Double‐Blind Phase 2 Trial

Hepatology
2021-10 | Journal article
Contributors: Samer Gawrieh; Mazen Noureddin; Nicole Loo; Rizwana Mohseni; Vivek Awasty; Kenneth Cusi; Kris V. Kowdley; Michelle Lai; Eugene Schiff; Deven Parmar et al.
Source: check_circle
Crossref

Prospective evaluation of the prevalence of non-alcoholic fatty liver disease and steatohepatitis in a large middle-aged US cohort

Journal of Hepatology
2021-08 | Journal article
Contributors: Stephen A. Harrison; Samer Gawrieh; Katharine Roberts; Christopher J. Lisanti; Ryan B. Schwope; Katherine M. Cebe; Valerie Paradis; Pierre Bedossa; Jennifer M. Aldridge Whitehead; Aymeric Labourdette et al.
Source: check_circle
Crossref

Relationship of ELF and PIIINP With Liver Histology and Response to Vitamin E or Pioglitazone in the PIVENS Trial

Hepatology Communications
2021-05 | Journal article
Contributors: Samer Gawrieh; Laura A. Wilson; Katherine P. Yates; Oscar W. Cummings; Eduardo Vilar‐Gomez; Veeral Ajmera; Kris V. Kowdley; William M. Rosenberg; James Tonascia; Naga Chalasani
Source: check_circle
Crossref

Role of candidate gene variants in modulating the risk and severity of alcoholic hepatitis

Alcoholism: Clinical and Experimental Research
2021-04 | Journal article
Contributors: James J. Beaudoin; Tiebing Liang; Qing Tang; Bubu A. Banini; Vijay H. Shah; Arun J. Sanyal; Naga P. Chalasani; Samer Gawrieh
Source: check_circle
Crossref

Interrogation of selected genes influencing serum LDL-Cholesterol levels in patients with well characterized NAFLD

Journal of Clinical Lipidology
2021-03 | Journal article
Contributors: Eduardo Vilar-Gomez; Samer Gawrieh; Tiebing Liang; Adam D. McIntyre; Robert A. Hegele; Naga Chalasani
Source: check_circle
Crossref

A perspective on RNA interference-based therapeutics for metabolic liver diseases

Expert Opinion on Investigational Drugs
2021-03-04 | Journal article
Contributors: Naim Alkhouri; Samer Gawrieh
Source: check_circle
Crossref

ADH1B∗2 Is Associated With Reduced Severity of Nonalcoholic Fatty Liver Disease in Adults, Independent of Alcohol Consumption

Gastroenterology
2020-09 | Journal article
Contributors: Eduardo Vilar-Gomez; Silvia Sookoian; Carlos Jose Pirola; Tiebing Liang; Samer Gawrieh; Oscar Cummings; Wanqing Liu; Naga P. Chalasani
Source: check_circle
Crossref

Letter to the Editor: Quantitative Histological Assessment in Nonalcoholic Fatty Liver Disease

Hepatology
2020-08 | Journal article
Contributors: Samer Gawrieh; David E. Kleiner; Naga Chalasani; Scott Vanderbeck
Source: check_circle
Crossref

Characteristics, aetiologies and trends of hepatocellular carcinoma in patients without cirrhosis: a United States multicentre study

Alimentary Pharmacology & Therapeutics
2019-10 | Journal article
Contributors: Samer Gawrieh; Lara Dakhoul; Ethan Miller; Andrew Scanga; Andrew deLemos; Carla Kettler; Heather Burney; Hao Liu; Hamzah Abu‐Sbeih; Naga Chalasani et al.
Source: check_circle
Crossref

Loci-specific differences in blood DNA methylation in HBV-negative populations at risk for hepatocellular carcinoma development

Epigenetics
2018-06-03 | Journal article
Contributors: Katarzyna Lubecka; Kirsty Flower; Megan Beetch; Jay Qiu; Lucinda Kurzava; Hannah Buvala; Adam Ruhayel; Samer Gawrieh; Suthat Liangpunsakul; Tracy Gonzalez et al.
Source: check_circle
Crossref

Automated assessment of steatosis in murine fatty liver

PLOS ONE
2018-05-10 | Journal article
Contributors: Deepak Sethunath; Pavel Strnad; Siripriya Morusu; Mihran Tuceryan; Oscar W. Cummings; Hao Zhang; Xiao-Ming Yin; Scott Vanderbeck; Naga Chalasani; Samer Gawrieh
Source: check_circle
Crossref

Peer review (7 reviews for 3 publications/grants)

Review activity for Clinical gastroenterology and hepatology (5)
Review activity for Gut (1)
Review activity for Nature communications (1)